Comparison of metabolic syndrome subjects with and without erectile dysfunction - Levels of circulating oxidised LDL and arterial elasticity

International Journal of Clinical Practice

Volumn 65, Issue 3, 2011, Pages 274-280

  Pohjantahti Maaroos H ^a,b,c   Palomaki A ^a,b  

^a KANTA HÄME CENTRAL HOSPITAL   (Finland)

^b Linnan Klinikka   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ARTERY ELASTICITY; ARTERY TONE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; ENZYME LINKED IMMUNOSORBENT ASSAY; ERECTILE DYSFUNCTION; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; RADIAL ARTERY; SYSTEMIC DISEASE; TONOMETER;

ADULT; ATHEROSCLEROSIS; EARLY DIAGNOSIS; ELASTICITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERECTILE DYSFUNCTION; HUMANS; IMPOTENCE, VASCULOGENIC; LIPOPROTEINS, LDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; QUESTIONNAIRES; RADIAL ARTERY; RISK FACTORS; VASCULAR STIFFNESS;

EID: 79951644345     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02595.x     Document Type: Article

References (44)

1. Montorsi P, Ravagnani P, Galli S, et al. Common grounds for erectile dysfunction and coronary artery disease. Curr Opin Urol 2004; 14: 361-5. (Pubitemid 39506930)
2. Thompson I, Tangen C, Goodman P, Probstfield J, Moinpour C, Coltman C,. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005; 294: 2996-3002. (Pubitemid 41817661)
3. Jackson G, Padley S,. Erectile dysfunction and silent coronary artery disease: abnormal computed tomography coronary angiogram in the presence of normal exercise ECGs. Int J Clin Pract 2008; 62: 973-6. (Pubitemid 351691507)
4. Inman B, Sauver J, Jacobson D, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 2009; 84: 108-13.
5. Vlachopoulos C, Rokkas K, Ioakeimidis N, Stefanadis C,. Inflammation, metabolic syndrome, erectile dysfunction and coronary artery disease: common links. Eur Urol 2007; 52: 1590-600. (Pubitemid 350052419)
6. Stocker R, Keaney JF Jr,. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381-478. (Pubitemid 39302636)
7. Holvoet P, Mertens A, Verhamme P, et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001; 21: 844-8. (Pubitemid 32448777)
8. Hulthe J, Fagerberg B,. Circulating Oxidized LDL is Associated with Subclinical Atherosclerosis Development and Inflammatory Cytokines (Air Study). Arterioscler Thromb Vasc Biol 2002; 22: 1162-7. (Pubitemid 34764868)
9. Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W,. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 2005; 112: 651-7. (Pubitemid 41099043)
10. Kirby M, Jackson G, Simonsen U,. Endothelial dysfunction links erectile dysfunction to heart Disease. Int J Clin Pract 2005; 59: 225-9. (Pubitemid 40331225)
11. Cohn J, Finkelstein S, McVeigh G, et al. Non- invasive Pulse Wave Analysis for the Early Detection of Vascular Disease. Hypertension 1995; 26: 503-8.
12. Boutouyrie P, Tropeano I, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients. A longitudinal study. Hypertension 2002; 39: 10-5. (Pubitemid 34098081)
13. Nigam A, Mitchell GF, Lambert J, Tardif JC,. Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease. Am J Cardiol 2003; 92: 395-9. (Pubitemid 36959874)
14. Lakka H-M, Laaksonen D, Lakka T, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-16. (Pubitemid 35403784)
15. Sigurdardottir V, Fagerberg B, Hulthe J,. Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men. J Intern Med 2002; 252: 440-7. (Pubitemid 36706575)
16. Fjeldstad A, Fjeldstad C, Acree L, et al. The relationship between arterial elasticity and metabolic syndrome features. Angiology 2007; 58: 5-10.
17. Pohjantähti-Maaroos H, Palomäki A, Kankkunen P, Laitinen R, Husgafvel S, Oksanen K,. Circulating oxidized low-density lipoproteins and arterial elasticity: comparison between men with metabolic syndrome and physically active counterparts. Cardiovasc Diabetol 2010; 9: 41.
18. Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final report. Circulation 2002; 106: 3143-421.
19. Aittasalo M, Miilunpalo S, Suni J,. The effectiveness of physical activity counseling in a work-site setting. A randomized controlled trial. Patient Educ Couns 2004; 55: 193-202. (Pubitemid 39458217)
20. Rosen R, Riley A, Wagner G, Osterloh I, Kirkpatrick J, Mishra A,. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 6: 822-30. (Pubitemid 27246947)
21. Nathan DM, Kuenen J, Borg R, et al. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008; 31: 1473-8.
22. Pai J, Curhan C, Cannuscio C, Rifai N, Ridker P, Rimm E,. Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection. Clin Chem 2002; 48: 1781-4.
23. Cohn J,. Vascular wall function as a risk marker for cardiovascular disease. J Hypertens 1999; 17: 41-4.
24. Conroy R, Pyörälä K, Fitzgerald A, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003. (Pubitemid 36712275)
25. Uslu N, Gorgulu S, Alper A, et al. Erectile dysfunction as a generalized vascular dysfunction. J Am Soc Echocardiogr 2006; 19: 341-6. (Pubitemid 43267459)
26. Kaya C, Ergelen M, Ilktac A, Karaman I,. Impaired elasticity of aorta in patients with erectile dysfunction. Urology 2007; 70: 558-62. (Pubitemid 47464485)
27. Vlachopoulos C, Aznaouridis K, Ioakeimidis N, et al. Arterial function and intima-media thickness in hypertensive patients with erectile dysfunction. J Hypertens 2008; 26: 1829-36.
28. Corona G, Mannucci E, Lotti F, et al. Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED. J Sex Med 2009; 6: 285-93.
29. Lojanapiwat B, Weerusawin T, Kuanprasert S,. Erectile dysfunction as a sentinel marker of endothelial dysfunction disease. Singapore Med J 2009; 50: 698.
30. Van Popele N, Grobbee D, Bots M, et al. Association between arterial stiffness and atherosclerosis. The Rotterdam study. Stroke 2001; 32: 454-60. (Pubitemid 32155234)
31. Billups KL,. Erectile dysfunction as an early sign of cardiovascular disease. Int J Impot Res 2005; 17: 19-24.
32. Araujo A, Hall S, Ganz P, et al. Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score. J Am Coll Cardiol 2010; 55: 350-6.
33. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practise. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 2007; 28: 2375-414.
34. Prisant LM, Loebl DH, Waller JL,. Arterial elasticity and erectile dysfunction in hypertensive men. J Clin Hypertens 2006; 8: 768-74.
35. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-605. (Pubitemid 44627304)
36. Kaiser D, Billups K, Mason C, Wetterling R, Lundberg J, Bank A,. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004; 43: 179-84. (Pubitemid 38201141)
37. Chiurlia E, D'Amico R, Ratti C, Granata A, Romagnoli R, Modena M,. Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J Am Coll Cardiol 2005; 46: 1503-6. (Pubitemid 41446186)
38. Yavuzgil O, Altay B, Zoghi M, Gürgün C, Kayikçioǧ lu M, Kültürsay H,. Endothelial function in patients with vasculogenic erectile dysfunction. Int J Cardiol 2005; 103: 19-26. (Pubitemid 41074599)
39. Barassi A, Colpi GM, Piediferro G, Dogliotti G, D'Eril GV, Corsi MM,. Oxidative stress and antioxidant status in patients with erectile dysfunction. J Sex Med 2009; 6: 2820-5.
40. Njajou OT, Kanaya AM, Holvoet P, et al. Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study. Diabetes Metab Res Rev 2009; 25: 733-9.
41. Cappelleri J, Rosen R, Smith M, Mishra A, Osterloh I,. Diagnostic evaluation of the erectile function domain of the international index of erectile function. Urology 1999; 54: 346-51. (Pubitemid 29367263)
42. O'Donnell AB, Araujo AB, Goldstein I, McKinlay JB,. The validity of a single-question self-report of erectile dysfunction. Results from the Massachusetts Male Aging Study. J Gen Intern Med 2005; 20: 515-9. (Pubitemid 41003806)
43. Bal K, Öder M, Şahin A, et al. Prevalence of metabolic syndrome and its association with erectile dysfunction among urologic patients: metabolic backgrounds of erectile dysfunction. Urology 2007; 69: 356-60. (Pubitemid 46274920)
44. Shabsigh R, Arver S, Channer K, et al. The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int J Clin Pract 2008; 62: 672-4.